As showed in Figure 2d, loss of the tumor-suppressor gene LRP1B was associated with elevated glycolysis in 11 separate tumor types, whereas gain of the AKT1 oncogene was associated with elevated glycolysis in five tumor types. Here, AKT1 is linked to neoplasm.